Patent directory · USPTO A61K / A61P
Patents matching “Rigel Pharmaceuticals, Inc.”
373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8377945
Small molecule inhibitors of spleen tyrosine kinase (SYK)
granted -
US 8377924
Protein kinase C inhibitors and uses thereof
granted -
US 8372415
Wet granulation using a water sequestering agent
granted -
US 8362235
Carboxamide compounds and methods for using the same
granted -
US 8349838
Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
granted -
US 8343954
Compositions and methods for inhibition of the JAK pathway
granted -
US 8334297
2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
granted -
US 8334296
2,4-pyrimidinediamine compounds and their uses
granted -
US 8324200
Compositions and methods for inhibition of the JAK pathway
granted -
US 8314107
Carboxamide compounds and methods for using the same
granted -
US 8314093
2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
granted -
US 8309566
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
granted -
US 8304422
Compositions and methods for inhibition of the JAK pathway
granted -
US 8299087
Compositions and methods for inhibition of the JAK pathway
granted -
US 8288382
Diaminothiazoles useful as Axl inhibitors
granted -
US 8278299
Pyrimidinediamine kinase inhibitors
granted -
US 8268851
Compositions and methods for inhibition of the JAK pathway
granted -
US 8263122
Wet granulation using a water sequestering agent
granted -
US 8246984
Formulation of insoluble small molecule therapeutics in lipid-based carriers
granted -
US 8227455
Methods of treating cell proliferative disorders
granted -
US 8211889
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
granted -
US 8211888
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
granted -
US 8193197
Compositions and methods for inhibition of the JAK pathway
granted -
US 8193181
Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine
granted